Drug Discovery Processes

Bristol Myers Squibb Buys Second NVIDIA DGX SuperPOD Built on Vera Rubin

BMS says the new cluster will sharply raise energy‑efficient GPU capacity to train foundation models and power agentic drug‑discovery workflows across its research sites.